Sectors Covered   Completed Transactions   Testimonials   Principals   M&A Report 
 and Publications 
 Contact Us 












Dynamic Healthcare M&A Database - 3Q07



Return to the Summary Page (3Q07)



Acquiring Party    Medco Health Solutions, Inc., a major pharmacy benefit manager.
Transferring Party    PolyMedica Corporation, a major provider of blood glucose testing supplies and related services for diabetics.
Sector    Medical Services
Date    August 28, 2007
Analysis
Medco manages more than $6.5b in drug spending related to its 2.8m patients under diabetes treatment. The deal brings 1 million members under care and creates a one-stop shop to provide supplies needed to monitor diabetes (under the Liberty brand) and medications to control it. Under pressure to disclose and share rebates received from pharmaceutical companies, PBMs are seeking other revenue sources. Rival Caremark RX (now part of CVS Caremark) acquired Accordant Health Services, a manager of chronic diseases, and Express Scripts bought Priority Healthcare Corp, a distributor of specialized drugs for certain disease states. Deal value -- $1.5b, on TTM revenue of $710.2m (2.1x) and EBITDA of $110.5 (13.5x).




The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones.

This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc.


The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.